类风湿关节炎足部疾病活动指数-5的研制与验证
本研究评估了新开发的类风湿关节炎足部疾病活动指数-5(RADAI-F5)的测量性能,该量表为患者报告结局工具,用于捕捉RA患者的足部疾病活动。研究纳入142例RA患者,评估结构效度、内容效度、纵向效度、内部一致性、1周重测信度及6个月反应性。结果显示RADAI-F5具有良好效度、信度和反应性,是临床可行的足部疾病活动测量工具。
要点
- RADAI-F5与mRADAI-5、FFI、FIS及DAS28-ESR呈理论一致的相关性,支持结构效度。
- RADAI-F5内部一致性高(Cronbach's α=0.90),1周重测信度良好(ICC=0.868)。
- 82%的患者认为RADAI-F5相关且易于理解,内容效度得到确认。
核心结论
- RADAI-F5是测量RA足部疾病活动的有效、可靠、反应性良好且临床可行的患者报告结局工具。
研究设计与样本
- 研究为测量性能评估,142例RA患者自填RADAI-F5、mRADAI-5、FFI和FIS,并记录DAS28-ESR,部分亚组在1周和6个月重测。
主要发现
- RADAI-F5与mRADAI-5相关系数0.789(95%CI 0.73,0.85),与FFI为0.713(95%CI 0.62,0.79)。
- RADAI-F5与FIS损伤/鞋具子量表相关系数0.695(95%CI 0.66,0.82,P<0.001),与FIS活动/参与子量表为0.478(95%CI 0.37,0.63,P<0.001)。
- RADAI-F5与DAS28-ESR相关系数0.379(95%CI 0.26,0.57,P<0.001)。
- 内部一致性Cronbach's α=0.90,重测信度ICC=0.868(95%CI 0.80,0.91,P<0.001),最小可检测变化为2.69。
- 82%的受访者认为RADAI-F5相关且易于理解。
关键数值与推荐
- RADAI-F5与mRADAI-5、FFI、FIS子量表及DAS28-ESR的相关性支持结构效度。
- 内部一致性Cronbach's α=0.90,重测信度ICC=0.868(95%CI 0.80,0.91),最小可检测变化=2.69。
- 82%的受访者评价RADAI-F5相关且易于理解,支持内容效度。
临床怎么用
- RADAI-F5可作为RA患者足部疾病活动的患者报告结局工具用于临床评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Omission of foot joints from composite global disease activity indices may lead to underestimation of foot and overall disease in rheumatoid arthritis (RA) and under-treatment. The aim of this study was to evaluate the measurement properties of the Rheumatoid Arthritis Foot Disease Activity Index-5 (RADAI-F5), a newly developed patient-reported outcome measure for capturing foot disease activity in people with RA. METHODS: Participants with RA self-completed the RADAI-F5, modified Rheumatoid Arthritis Disease Activity Index (mRADAI-5), Foot Function Index (FFI), and Foot Impact Scale (FIS) impairment/footwear and activity/participation subscales. The 28-joint Disease Activity Score using the erythrocyte sedimentation rate (DAS28-ESR) was also recorded. Subgroups completed the RADAI-F5 at 1 week and 6 months. Psychometric properties, including construct, content and longitudinal validity, internal consistency, 1-week reproducibility, and responsiveness over 6 months were evaluated. RESULTS: Of 142 respondents, 103 were female, with a mean ± SD age of 55 ± 12.5 years and median RA disease duration of 10 (interquartile range 3.6-20.8) months. Theoretically consistent associations confirming construct validity were observed with mRADAI-5 (0.789 [95% confidence interval (95% CI) 0.73, 0.85]), FFI (0.713 [95% CI 0.62, 0.79]), FIS impairment/footwear (0.695 [95% CI 0.66, 0.82], P < 0.001), FIS activity/participation (0.478 [95% CI 0.37, 0.63], P < 0.001), and the DAS28-ESR (0.379 [95% CI 0.26, 0.57], P < 0.001). The RADAI-F5 demonstrated high internal consistency (Cronbach's α = 0.90) and good reproducibility (intraclass correlation coefficient = 0.868 [95% CI 0.80, 0.91], P < 0.001, smallest detectable change = 2.69). Content validity was confirmed, with 82% rating the instrument relevant and easy to understand. CONCLUSION: The RADAI-F5 is a valid, reliable, responsive, clinically feasible patient-reported outcome measure for measuring foot disease activity in RA.
引用
- Hoque A, Gallagher K, McEntegart A, et al. Measuring Inflammatory Foot Disease in Rheumatoid Arthritis: Development and Validation of the Rheumatoid Arthritis Foot Disease Activity Index-5. Arthritis Care Res (Hoboken). 2021. PMID: 32433810. doi:10.1002/acr.24259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。